• 1. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 2. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 3. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 4. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 5. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466

Introduction to 2-Amino-3-chloro-6-(difluoromethyl)pyridine (CAS No. 1805959-14-1)

2-Amino-3-chloro-6-(difluoromethyl)pyridine, identified by the Chemical Abstracts Service Number (CAS No.) 1805959-14-1, is a significant compound in the realm of pharmaceutical and agrochemical research. This heterocyclic aromatic amine features a pyridine core substituted with an amino group at the 2-position, a chloro group at the 3-position, and a difluoromethyl group at the 6-position. The unique structural arrangement of these substituents imparts distinct chemical properties, making it a valuable intermediate in synthetic chemistry and a promising candidate for developing novel bioactive molecules.

The compound's molecular structure, characterized by its electron-withdrawing and electron-donating groups, influences its reactivity and interaction with biological targets. The presence of the amino group enhances its potential for further functionalization, while the chloro and difluoromethyl substituents contribute to its stability and metabolic resistance. These attributes make 2-Amino-3-chloro-6-(difluoromethyl)pyridine a versatile building block for medicinal chemists seeking to design molecules with enhanced pharmacological profiles.

In recent years, there has been growing interest in pyridine derivatives due to their broad spectrum of biological activities. Research has demonstrated that such compounds exhibit inhibitory effects on various enzymes and receptors, making them relevant in the development of drugs targeting neurological disorders, infectious diseases, and cancer. Specifically, derivatives of this class have shown promise in preclinical studies as kinase inhibitors and antimicrobial agents.

One of the most compelling aspects of 2-Amino-3-chloro-6-(difluoromethyl)pyridine is its role in the synthesis of small-molecule inhibitors that modulate protein-protein interactions. The pyridine ring serves as a scaffold that can be modified to achieve high specificity for target proteins. For instance, studies have highlighted its utility in creating inhibitors of Janus kinases (JAKs), which are involved in inflammatory signaling pathways. The incorporation of the difluoromethyl group has been particularly noted for its ability to improve binding affinity and reduce metabolic clearance, thereby enhancing drug efficacy.

The agrochemical sector has also benefited from the exploration of pyridine-based compounds. 2-Amino-3-chloro-6-(difluoromethyl)pyridine has been employed in the synthesis of novel herbicides and fungicides that exhibit improved environmental compatibility while maintaining high efficacy against pests and pathogens. The structural features of this compound allow for fine-tuning of its biological activity, enabling researchers to develop products with targeted modes of action.

Advances in computational chemistry have further accelerated the discovery process for derivatives of 2-Amino-3-chloro-6-(difluoromethyl)pyridine. Molecular modeling techniques predict how different substituents will influence the compound's interactions with biological targets, guiding synthetic efforts toward more potent and selective molecules. This interdisciplinary approach combines experimental synthesis with theoretical analysis to streamline drug development pipelines.

The synthesis of 2-Amino-3-chloro-6-(difluoromethyl)pyridine itself presents interesting challenges due to the need for precise regioselectivity during functionalization. Researchers have developed innovative synthetic routes that leverage transition metal catalysis and organometallic chemistry to construct the desired framework efficiently. These methodologies not only improve yield but also minimize byproduct formation, aligning with green chemistry principles.

Recent patents have emerged that detail novel applications for 2-Amino-3-chloro-6-(difluoromethyl)pyridine in therapeutic areas such as antiviral and anti-inflammatory treatments. For example, modifications to this core structure have yielded compounds that disrupt viral replication mechanisms or inhibit inflammatory cytokines. Such findings underscore the compound's versatility as a starting point for drug discovery initiatives.

The regulatory landscape for new chemical entities like 2-Amino-3-chloro-6-(difluoromethyl)pyridine continues to evolve, emphasizing safety and environmental considerations without stifling innovation. Manufacturers must navigate stringent guidelines while ensuring that their processes are sustainable and scalable for commercial production. This balance is critical for bringing promising candidates from laboratory research to market-ready pharmaceuticals or agrochemicals.

Looking ahead, the future research directions for 2-Amino-3-chloro-6-(difluoromethyl)pyridine may include exploring its potential in photopharmacology—where light activation can modulate drug activity—and its incorporation into prodrug formulations that enhance bioavailability or targeted delivery systems. The compound's unique structural features make it an attractive candidate for these emerging fields.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)